Wnt3a	O
signal	O
pathways	O
activate	O
MyoD	O
expression	O
by	O
targeting	O
cis	O
-	O
elements	O
inside	O
and	O
outside	O
its	O
distal	O
enhancer	O
.	O


Wnt	O
proteins	O
are	O
secreted	O
cytokines	O
and	O
several	O
Wnts	O
are	O
expressed	O
in	O
the	O
developing	O
somites	S-TISSUE
and	O
surrounding	O
tissues	O
.	O


Without	O
proper	O
Wnt	O
stimulation	O
,	O
the	O
organization	O
of	O
the	O
dermomyotome	S-TISSUE
and	O
myotome	S-TISSUE
can	O
become	O
defective	O
.	O


These	O
Wnt	O
signals	O
received	O
by	O
somitic	B-TISSUE
cells	E-TISSUE
can	O
lead	O
to	O
activation	O
of	O
Pax3	O
/	O
Pax7	O
and	O
myogenic	O
regulatory	O
factors	O
(	O
MRFs	O
)	O
,	O
especially	O
Myf5	O
and	O
MyoD	O
.	O


However	O
,	O
it	O
is	O
currently	O
unknown	O
whether	O
Wnts	O
activate	O
Myf5	O
and	O
MyoD	O
through	O
direct	O
targeting	O
of	O
their	O
cis	O
-	O
regulatory	O
elements	O
or	O
via	O
indirect	O
pathways	O
.	O


To	O
clarify	O
this	O
issue	O
,	O
in	O
the	O
present	O
study	O
,	O
we	O
tested	O
the	O
regulation	O
of	O
MyoD	O
cis	O
-	O
regulatory	O
elements	O
by	O
Wnt3a	O
secreted	O
from	O
human	O
embryonic	O
kidney	B-TISSUE
(	I-TISSUE
HEK	I-TISSUE
)	I-TISSUE
-	I-TISSUE
293T	I-TISSUE
cells	E-TISSUE
.	O


We	O
found	O
that	O
Wnt3a	O
activated	O
the	O
MyoD	O
proximal	O
6	O
.	O
0k	O
promoter	O
(	O
P6P	O
)	O
only	O
marginally	O
,	O
but	O
highly	O
enhanced	O
the	O
activity	O
of	O
the	O
composite	O
P6P	O
plus	O
distal	O
enhancer	O
(	O
DE	O
)	O
reporter	O
through	O
canonical	O
and	O
non	O
-	O
canonical	O
pathways	O
.	O


Further	O
screening	O
of	O
the	O
intervening	O
fragments	O
between	O
the	O
DE	O
and	O
the	O
P6P	O
identified	O
a	O
strong	O
Wnt	O
-	O
response	O
element	O
(	O
WRE	O
)	O
in	O
the	O
upstream	O
-	O
8	O
to	O
-	O
9k	O
region	O
(	O
L	O
fragment	O
)	O
that	O
acted	O
independently	O
of	O
the	O
DE	O
,	O
but	O
was	O
dependent	O
on	O
the	O
P6P	O
.	O


Deletion	O
of	O
a	O
Pax3	O
/	O
Pax7	O
-	O
targeted	O
site	O
in	O
the	O
L	O
fragment	O
significantly	O
reduced	O
its	O
response	O
to	O
Wnt3a	O
,	O
implying	O
that	O
Wnt3a	O
activates	O
the	O
L	O
fragment	O
partially	O
through	O
Pax3	O
/	O
Pax7	O
action	O
.	O


Binding	O
of	O
beta	O
-	O
catenin	O
and	O
Pax7	O
to	O
their	O
target	O
sites	O
in	O
the	O
DE	O
and	O
the	O
L	O
fragment	O
respectively	O
was	O
also	O
demonstrated	O
by	O
ChIP	O
.	O


These	O
observations	O
demonstrated	O
the	O
first	O
time	O
that	O
Wnt3a	O
can	O
directly	O
activate	O
MyoD	O
expression	O
through	O
targeting	O
cis	O
-	O
elements	O
in	O
the	O
DE	O
and	O
the	O
L	O
fragment	O
.	O
